Skip to content


Volume 17 Supplement 4

Sepsis 2013

  • Poster presentation
  • Open Access

Intravenous immunoglobulin therapy could have efficacy in severe sepsis

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Critical Care201317 (Suppl 4) :P39

  • Published:


  • Body Temperature
  • Septic Shock
  • Severe Sepsis
  • Septic Patient
  • International Guideline


Intravenous immunoglobulin (IVIG) administration has been approved to use for severe sepsis with antibiotics by the Ministry of Health, Labour and Welfare since 1980 in Japan. IVIGs are commonly used for severe sepsis and septic shock in Japan, while the international guidelines for management of severe sepsis and septic shock in 2012 suggest not using IVIG in adult patients. Our hypothesis is that IVIG administration has an efficacy for severe sepsis and septic shock.

Materials and methods

This retrospective observational study included all adult patients in our ICU who were administered IVIG for severe sepsis and septic shock from January 2011 to June 2013. IVIG was used at 5,000 mg/day every 24 hours for 3 days. We compared body temperature (°C), WBC (/mm3), CRP (mg/dl), procalcitonin (ng/ml) and serum immunoglobulin G (IgG) (mg/dl; normal >870) between before and after IVIG treatment. Values are expressed as the median. The Wilcoxon signed-rank test was used for the statistical analysis. P < 0.05 was considered significant.


One hundred and fifty-one patients (85 men, 66 women; age range 23 to 96 (median 67.8)) were included in this study. The 28-day mortality after IVIG treatment was 13.9%. The SOFA score before IVIG treatment was 5.0. Values of WBC, CRP and procalcitonin were significantly decreased after IVIG treatment (10,905 vs. 9,805, P < 0.0001, 12.3 vs. 7.7, P < 0.0001, 2.4 vs. 1.7, P = 0.0003, respectively). Body temperature did not significantly change (37.4 vs. 37.2, P = 0.07). Serum IgG was significantly increased after the treatment (1,046 vs. 1,563, P = 0.003).


The present study has some limitations because of being a retrospective observational study. However, the mortality was quite low in the group of patients included in this study. Moreover, after IVIG treatment values of WBC, CRP and procalcitonin were improved. The median value of serum IgG before treatment was within the normal range, but after treatment was also significantly improved. There is a possibility that severe septic patients require additional IgG regardless of its normal concentrations in their blood.

Authors’ Affiliations

Department of Critical Care and Emergency Medicine, Tokyo Women's Medical University, Tokyo, Japan


© Kim et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.